Physiologically based pharmacokinetic modelling of oral and intranasal formulations of zolmitriptan in healthy volunteers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504492-24-00

Acronym

IMIMFCTL/ZOL_1

Enrollment

Registered

2023-07-03

Start date

2023-07-12

Completion date

2023-09-26

Last updated

2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026